Articles related to CLINICAL TRIALS

Results from the TRAILBLAZER-ALZ 2 trial highlight the efficacy of donanemab in slowing the progression of early symptomatic Alzheimer disease over a period of 76 weeks.

Join historian Susan W. Wade, Ph.D., in exploring her personal experience with vulvar cancer and participation in an experimental clinical trial. Wade’s firsthand account offers not only medical insights but a deeper understanding of the patient’s psychological journey and a reflection on the future of oncology treatments.

Selinexor has demonstrated an extraordinary extension in progression-free survival in patients with wild-type TP53 advanced or recurrent endometrial cancer, according to the recent findings from the SIENDO study.

The phase 3 study evaluating cilta-cel, a BCMA–directed CAR T-cell therapy, in patients with lenalidomide-refractory multiple myeloma indicates promising results in progression-free survival and overall response rates.

The recent phase 3 trial on pitavastatin’s effectiveness in HIV-infected patients opens new avenues in cardiovascular disease prevention within this demographic. Physicians may find the detailed insights on risk reduction and side effects beneficial in tailoring personalized care strategies.

Uncover the potential of dupilumab in managing COPD patients with type 2 inflammation as this Phase 3 trial reveals fewer exacerbations, improved lung function, and enhanced life quality among the treated cohort.